ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Saxagliptin iMpurity
Saxagliptin iMpurity
- CAS No.
- 2173146-35-3
- Chemical Name:
- Saxagliptin iMpurity
- Synonyms
- Saxagliptin iMpurity;Saxagliptin Impurity 17 HCl;(1S,3S,5S)-2-((S)-2-Amino-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile;(1S,3S,5S)-2-((S)-2-Amino-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride
- CBNumber:
- CB92686720
- Molecular Formula:
- C18H24ClN3O2
- Molecular Weight:
- 349.86
- MOL File:
- 2173146-35-3.mol
Saxagliptin iMpurity Preparation Products And Raw materials
Raw materials
Preparation Products
Saxagliptin iMpurity Suppliers
Global( 20)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD | 0755-0755-0755-83725350 13380397412 | China | 10071 | 58 | Inquiry |
Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
Nanjing Yongyi Pharma Tech Co. , Ltd. | 13770533061 | China | 463 | 58 | Inquiry |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 | China | 5000 | 58 | Inquiry |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | China | 18865 | 58 | Inquiry |
Shandong Wadesen Biotechnology Co. LTD | 0531-88723173 18596073690 | China | 3943 | 58 | Inquiry |
HX Pharmaceutical technology co., LTD | 15671363360 | China | 2808 | 58 | Inquiry |
Chengdu Novel Biomedical Co., Ltd. | 028-85255396 18302801538 | China | 2286 | 58 | Inquiry |
Shenzhen Popeye Biotechnology Co. Ltd. | 0755-86320212 | China | 310 | 58 | Inquiry |
2173146-35-3(Saxagliptin iMpurity)Related Search:
Tolvaptan
Ibrutinib
Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-diMethylethoxy)carbonyl]aMino]-3,5-dihydroxy-, (αS)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
(1R,3R,5R)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
Saxagliptin Impurity 34
3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one, 6-aMino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
(R)-N-Boc-3-hydroxyadaMantylglycine
(1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
1H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione, hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)-
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
chevron_left
1of4
chevron_right
Saxagliptin iMpurity
Saxagliptin Impurity 17 HCl
(1S,3S,5S)-2-((S)-2-Amino-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(1S,3S,5S)-2-((S)-2-Amino-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride
2173146-35-3
1564265-00-7
1564265-03-0
ZY